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ABSTRAK 
 
Gangguan gastrointestinal fungsional (GGIF) mewakili gangguan yang sering dijumpai dan perlu 
mendapatkan perhatian dalam bidang gastroenterologi.  Gangguan ini menyebabkan kecemasan, distress dan 
morbiditas. Pasien dengan gangguan ini sering memperlihatkan manifestasi klinis secara tumpang tindih. 
Pasien dispepsia fungsional seringkali tumang tindih dengan gangguan gastrointestinal lain, termasuk nyeri 
anorektal fungsional.  Keadaan tumpang tindih ini dapat menimbulkan keluhan yang makin berat, kualitas 
hidup yang lebih buruk dan skor somatisasi yang lebih tinggi, dan pasien mengalami kecemasan, depresi atau 
insomnia lebih sering dibandingkan pasien yang tanpa problem tumpah tindih. GGIF ditegakkan 
berdasarkan kriteria Rome III dan eksklusi penyakit organik. Pendekatan multimodalitas dibutuhkan dalam 
mengatasi pasien yang menderita gangguan gastrointestinal fungsional. Pada tinjaun kasus ini, dilaporkan 
seorang pasien laki laki menderita gangguan dispepsia fungsional dan nyeri anorektal fungsional tidak spesifik. 
 
Kata kunci : gangguan gastrointestinal fungsional, dyspepsia fungsional, nyeri anorektal fungsional 
 
ABSTRACT 
 
Functional gastrointestinal disorders (FIGD) represent a common and important class of disorders 
within gastroenterology. FIGD are a cause of great anxiety, distress and morbidity. FIGD disorders maybe 
manifest as overlapping syndrome. Patients with functional dyspepsia (FD) show frequent overlapping of 
other gastrointestinal disease, such as functional anorectal pain. These overlap patients have more frequent 
or more severe symptoms, poor health related quality of life and higher somatization scores, and they are 
more likely to experience anxiety, depression or insomnia compared to non-overlap patients. These disorders 
were diagnosed according Rome III criteria and excluded structural diseases. Multimodalities approach 
should be used during treatment patient with FGID. It was reported a male patient with functional dyspepsia 
and unspecified functional anorectal pain overlap. 
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INTRODUCTION  
 
Functional gastrointestinal disorders 
(FGID) represent a common and important 
class of disorders within gastroenterology that 
are characterized by persistent and recurring 
GI symptoms.   The prevalence of FGID in 
Taiwan was 26.2%. Unspecified functional 
bowel disorder was the most prevalent (8.9%), 
followed by functional dyspepsia (5.3%), 
irritable bowel syndrome (4.4%) and 
functional constipation (4.4%).1 The large 
number of patients suffering from FIGDs, as 
well as the high frequency of functional GI 
symptoms in general within the population, 
the health care burden produced by the uses 
of medical services and medications for these 
conditions, and its eventual outcome in terms 
of work absenteeism are well known.2  FIGD 
disorders maybe manifest as overlapping 
syndrome.  Patients with functional dyspepsia 
(FD) show frequent overlapping of other 
gastrointestinal disease such as irritable bowel 
syndrome (IBS), gastroesophageal reflux 
disease (GERD), gastroparesis, functional 
anorectal pain and non-gastrointestinal 
disease (fibromyalgia, chronic fatigue, painful 
bladder syndrome).  These overlap patients 
have more frequent or more severe 
symptoms, poor health related quality of life 
and higher somatization scores, and they are 
more likely to experience anxiety, depression 
or insomnia compared to non-overlap 
patients.3,4   In this case report we described 
how to diagnose and manage patient with    
functional dyspepsia and functional anorectal 
pain overlap.  
 
CASE REPORT 
A 36 years’ man was referred to 
Gastroenterology and Hepatology Clinic, at 
Sardjito General Hospital, Yogyakarta, 
Indonesia, because of chronic dyspepsia and 
anorectal pain. He suffered from bloating, 
early satiety, nausea, loss of appetite, and 
anorectal pain about 3 years.  He told that 
anorectal pain was sharp, precipitated or 
worsened by defecation (arising   about 30 
minutes after defecation), sitting and the pain 
lasting for some hours.  According visual 
analogue scale (VAS), the severity of 
anorectal pain was 7 – 8. He described no 
change in bowel habit, and had average 5 – 7 
bowel movements (defecation) weekly, 
passed with minimal straining, no rectal 
bleeding and mucus discharge. The urinary 
habit was normal. There was no history of 
back pain, trauma or pelvic surgery. His 
unresolved symptoms caused emotional 
distress, impaired vitality, problems with food 
and drink, impairment in daily function 
(inability to work), and the body weight 
reduced about 10 kilograms.  
 General physical examination, 
including abdominal and neurological 
examination were normal. Anal   examination 
showed no perineal disease, hemorrhoid, 
fissures or mass.  Anal canal tone and 
squeeze were normal (no tenderness with 
posterior traction of the puborectalis 
muscles). Palpation of the coccyx is not 
painful and no masses were felt.   A complete 
blood count, sedimentation rate and 
abdominal ultrasound were normal. Coccyx 
x-ray, abdominal and pelvis multi-slice CT 
scan were normal.  Gastroscopy examination 
was also normal. During colonoscopy 
examination there were not found tenderness, 
erosion, bleeding, ulcer, or mass in recto-
sigmoid area, except of first grade or mild 
internal hemorrhoid. A nutrient drink test 
was conducted for detecting impaired gastric 
accommodation.  After fasting about 8 hours, 
he was asked to ingest a nutrient drinking test 
(UltraMilk which contains 0.6 kcal/mL). The 
maximum tolerated volume that ingested by 
the patient was 650 mL. VAS score (100 mm 
scale) was used to measure postprandial 
dyspepsia symptoms. The VAS score for 
postprandial symptoms were; for nausea 70, 
bloating 100, epigastric pain 0, fullness 100, 
and total symptoms score was 270.  The diagnosis 
of the patient was functional dyspepsia with 
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unspecified functional anorectal pain. 
Information and education, low fat diet, 
domperidone 3 times daily, lansoprazole 2 times 
daily, amitriptyline 12.5 mg in the night and 
spiritual approach (latihan pasrah diri) were 
prescribed for managing these problems.   
DISCUSSION 
The Rome III have classified FGIDs into 
6 major domains for adults: 1) functional 
esophageal, 2) functional gastroduodenal 
(functional dyspepsia, belching disorders, nausea 
and vomiting disorders, rumination syndrome), 3) 
functional bowel disorders, 4) functional 
abdominal pain, 5) functional gallbladder and 
sphincter of Oddi disorders, 6) functional 
anorectal disorders (functional fecal incontinence, 
functional anorectal pain).5   Drossman (2006) 
described the pathophysiology of FGID 
conceptual model. In this model, interactions 
between early in life conditions (genetic and 
environment), psychosocial factors (life stress, 
psychologic state, coping to stress, social support), 
physiology (motility, sensation, inflammation, 
altered bacterial flora, brain – gut axis) induced 
GI symptoms and outcome (medications, medical 
doctor visits, quality of life). 
Because routine test like x-rays, CT scans 
and other used for diagnosing organic disorders 
are generally negative for people with FGID, 
diagnosing these disorders cannot be based on 
test results. Rome III criteria are used to establish 
the diagnose of FGID.  According the  Rome III 
criteria, functional dyspepsia is defined as the 
presence of symptoms thought originate in the 
gastroduodenal region in the absence  of any 
organic, systemic, or metabolic disease likely to 
explain the symptoms, for the last 3 months with 
symptom onset at least 6 months prior to 
diagnosis.6   Functional dyspepsia is now further 
subdivided into two new diagnostic categories: (1) 
meal-induced dyspeptic symptoms or 
postprandial distress syndrome (PDS), 
characterized by postprandial fullness and early 
satiation, and (2) epigastric pain syndrome (EPS), 
characterized by epigastric pain and burning.7    
Dysmotility (impaired gastric 
accommodation and visceral hypersensitivity) is a 
main focus of research in the pathophysiology of 
dyspepsia.  In functional dyspepsia, impairment 
of accommodation has been found in 40% of 
cases.8   Drink test were originally developed as a 
noninvasive means to assess upper digestive 
sensations and, perhaps, gastric accommodation. 
It procedures were developed as a symptom 
provocative technique for the patients with 
dyspeptic complaints.9   Accommodation is the 
ability of the stomach to distend appropriately to 
the size and timing of a meal, allowing an increase 
in gastric volume without an increase pressure. 
Because of impaired gastric accommodation, meal 
ingested was distributed to distal stomach 
(antrum).8 Meal ingestion is an important trigger 
for dyspeptic symptoms in majority of the FD 
patients.  
Functional dyspeptic patients will often 
achieve satiation at lower drink test volume and 
report greater symptoms, than controls. Loza et 
al10 reported that FD patients ingested (Nutren 
Nestle) maximum volume 652±168 mL 
compared controls 1278±275 mL (p= 0.001) and 
total score dyspepsia symptoms for FD patients 
187±26 compared controls 64±8.9 (p=0.001). 
Using the 10th percentile as the lower limit of the 
normal range, volume < 800 mL of nutridrink for 
men and < 600 mL for women were considered 
abnormal.9 Our patient ingested only 650 mL 
with total dyspeptic symptoms was 270. This 
condition supported that the patient suffered 
from impaired gastric accommodation. The 
diagnostic of our patient was functional dyspepsia 
that confirmed according The Rome III criteria. 
According Rome III, functional anorectal 
pain is divided into chronic proctalgia (levator ani 
syndrome and unspecified functional anorectal 
pain) and proctalgia fugax. Chronic proctalgia is a 
general term for chronic or recurring pain in the 
anal canal or rectum. Other names considered 
synonymous with chronic proctalgia are levator 
ani syndrome, chronic idiopathic perineal pain, 
pyriformis syndrome, and pelvic tension myalgia. 
Chronic tension or spasm of the striated muscles 
of the pelvic floor (levator ani muscles: 
pubococcygeus and iliococcygeus) is commonly 
assumed to be the pathophysiological basis for 
chronic proctalgia.11 
Table 1 show diagnosis criteria for 
functional anorectal pain  according Rome III.  
The two functional anorectal pain disorders 
(chronic proctalgia and proctalgia fugax) are 
distinguished on the basis of duration, frequency, 
and characteristic quality of pain. It is necessary 
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to exclude other causes of anorectal pain such as 
ischemia, fissures, and inflammation. In our case, 
the diagnosis was unspecified functional anorectal 
pain that established based on the Rome III 
criteria, and it was supported by no other causes 
of structural anorectal diseases.5,12 
Diagnostic approach for patient with 
chronic or recurrent anorectal pain are history 
taking, physical examination, complete blood 
count, erythrocyte sedimentation rate (ERS), 
biochemistry panel, flexible sigmoidoscopy (or 
colonoscopy), and perianal imaging with 
ultrasound or MRI, to exclude structural diseases 
(figure 1).13   When structural diseases were 
excluded and the pain is not associated with 
bowel movements or eating, functional anorectal 
pain should be thought. 
The differential diagnosis functional 
anorectal pain is anal fissure, coccygodynia, and 
pudendal neuralgia. Patient presenting with anal 
fissure complain of pain during and after passage 
of the stool.  
 
Table 1. Diagnosis criteria for functional anorectal 
pain according Rome III (Drossman, 2006). 5,12,13 
*Criteria fulfilled for the last 3 months with symptom 
onset at least 6 months prior to diagnosis 
On digital examination, a chronic fissure feels 
rough, raised, or fibrotic in the mid distal anal 
canal. 14 Coccydynia is defined as pain arising in 
or around the coccyx, usually triggered by 
prolonged sitting on hard surfaces. 14 In this case 
coccygodynia was excluded because there was no 
pain during manipulation of the coccyx, no 
history of trauma and normal coccyx on x- ray 
investigation.  Pudendal neuralgia is a chronic 
pain in the perineal area secondary to entrapment 
and injury to the pudendal nerve in its musculo-
osteo-aponeurotic tunnel between the 
sacrotuberal and sacrospinal ligaments, in the 
absence of organic diseases that may explain the 
symptoms. Pudendal neuralgia was not 
concordance with this case, because the 
superficial pain, burning sensation, numbness, or 
paresthesia in the gluteal, perianal, and or genital 
area were not found. 14  
Patients suffered from FGID, especially 
functional dyspepsia and functional anorectal pain 
need multimodalities approach, such as:  
information and education, reassurance, diet and 
medication, antidepressant treatment, 
psychological support, electrical stimulation of 
pelvic floor muscles, biofeedback to teach 
relaxation the muscles, massage of the levator ani 
muscles, botulinum injections.  FGID are a cause 
of great anxiety, distress and morbidity.  
Psychological treatment helps to reduce anxiety 
levels and symptoms. 5 The intent-to-treat 
analysis showed that 87% reported adequate relief 
of rectal pain following bio-feedback, compared 
with 45% for electrical stimulation and 22% for 
digital massage, relief was well maintained for 12 
months of follow up.12   Antidepressants are used 
in the of functional dyspepsia and abdominal pain 
based on three propositions:  1) antidepressants 
could reduce anxiety and depression, 2) 
antidepressants have central analgesic actions, 3) 
these drugs  may have local pharmacological 
actions on  the upper gut. 15    Park et al 16 
reported that low dose amitriptyline (10 mg at 
bedtime) combined with proton pump inhibitor 
for functional dyspepsia   was more effective than 
a double dose of PPI. Clinicians prescribing 
antidepressants should keep in mind that the 
therapeutic benefit may take 4 to 6 weeks to 
achieve and treatment can be started at low dose. 
17  
CONCLUSION  
 It was reported a patient with functional 
dyspepsia and unspecified functional anorectal 
pain overlap. These disorders were diagnosed 
according Rome III criteria and excluded 
Acta Interna The Journal of Internal Medicine Vol. 6 No. 1 June 2016 
Website Journal : http://jurnal.ugm.ac.id/jain 
 
5 
 
structural diseases. Multimodalities approach 
should be used during treatment patient with 
FGID.  
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